Trials in Baltimore, Maryland
Here are the top 10 medical studies for lung cancer in Baltimore, Maryland
Popular Filters
Phase 3 Trials
PD-L1 Inhibitor
Rilvegostomig + Pembrolizumab + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
"This trial is comparing the effectiveness and safety of rilvegostomig with pembrolizumab, when used alongside platinum-based chemotherapy, for treating patients with a specific type of lung cancer
Checkpoint Inhibitor
Nivolumab + Relatlimab vs Pembrolizumab with Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Lancaster, Pennsylvania
This trial aims to compare how well two different drug combinations (Nivolumab and Relatlimab with chemotherapy versus Pembrolizumab with chemotherapy) work in treating participants with advanced or recurrent
Monoclonal Antibodies
BNT327 + Chemotherapy for Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Fredericksburg, Virginia
"This trial aims to compare the effectiveness of two different treatment combinations for small-cell lung cancer in patients who have not been treated before. One combination includes BNT327 with chemotherapy, while the other includes at
Monoclonal Antibodies
Treatment Timing for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Elkton, Maryland
This trial compares giving standard therapy after surgery to giving standard therapy before and after surgery in patients with a specific type of lung cancer that can be removed by surgery. The goal is to determine which approach is
Trials With No Placebo
PD-L1 Inhibitor
Rilvegostomig + Pembrolizumab + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
"This trial is comparing the effectiveness and safety of rilvegostomig with pembrolizumab, when used alongside platinum-based chemotherapy, for treating patients with a specific type of lung cancer
Monoclonal Antibodies
AMG 193 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial aims to determine how safe and effective two different doses of AMG 193 are, as assessed by the researchers. Additionally, the study will evaluate how well AMG 193 works on its
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.